Merit Medical Systems Inc

Merit Medical's RSI of 33.3 signals oversold conditions despite a valuation that remains stretched at 26x earnings—an unusual disconnect suggesting either capitulation selling or legitimate profit-taking from elevated levels. With the stock trading well below its 52-week high and short interest at 6.68% of float, there's limited squeeze ammunition, though the depressed momentum reading could attract mean-reversion buyers. The modest short position and medical device sector tailwinds create a potential technical bounce setup, but the elevated multiple offers little margin of safety at current prices, making this territory between repair lows and full recovery.